Skip to content

SoftWave Provider? Click here to learn more about SoftWaveClinics.com

Shockwave Therapy Clinical Studies

  • No categories
  • Biologic Response
  • Bone Healing
  • Brain, Spine and Nerve
  • Cancer Research
  • Cardiology Research
  • Cosmetics / Aesthetics Research
  • Dental Research
  • FDA Research
  • Integrative Medicine
  • Modulation of Inflammation
  • Opioid Addiction Research
  • Organ Regeneration
  • Physics
  • Respiratory/Coronavirus
  • Sexual Health Research
  • SoftWave Literature
  • Sports Medicine Orthopedics
  • Stem Cells Research
  • Urology
  • Veterinary
  • Wound Care Research
    • Shockwave Therapy Stimulates Angiogenesis to Treat Ischemic Heart Disease

    Shockwave Therapy Stimulates Angiogenesis to Treat Ischemic Heart Disease

    Title of study: Antimicrobial peptide LL37/RNA complexes stimulate Toll-like receptor 3 upon shock wave therapy of ischemic muscle Author: Can Gollmann-Tepeköylü, Michael Graber, Daniela Lobenwein, E. Kirchmair, M. Grimm, Johannes Holfeld Shockwave therapy (SWT) is a promising treatment for ischemic...
    Learn more about Shockwave Therapy Stimulates Angiogenesis to Treat Ischemic Heart Disease
    In vitro extracorporeal shock wave treatment has beneficial effects on rat Schwann cell isolation and culture

    In vitro extracorporeal shock wave treatment has beneficial effects on rat Schwann cell isolation and culture

    Introduction: As new approaches for peripheral nerve regeneration are sought, there is an increasing demand for native Schwann cells for in vitro testing and/or reimplantation. Extracorporeal shockwave treatment (ESWT) is an emergent technology in the field of regenerative medicine, which...
    Learn more about In vitro extracorporeal shock wave treatment has beneficial effects on rat Schwann cell isolation and culture
    Shock wave therapy enhances neuronal sprouting and improves neuronal survival

    Shock wave therapy enhances neuronal sprouting and improves neuronal survival

    Shock wave therapy enhances neuronal sprouting and improves neuronal survival   Background: Shock wave therapy (SWT) has been shown to induce tissue regeneration and improve function in spinal cord ischemia via TLR3. Thereby, induction of angiogenesis and alteration of microglial...
    Learn more about Shock wave therapy enhances neuronal sprouting and improves neuronal survival
    Shock wave treatment reduces neuronal degeneration

    Shock wave treatment reduces neuronal degeneration

    Shock wave treatment reduces neuronal degeneration upon spinal cord ischemia via a Toll-like receptor 3 dependent mechanism   OBJECTIVES: Paraplegia following spinal cord ischemia represents the most severe complication of aortic surgery. Shock wave treatment (SWT) was shown to induce...
    Learn more about Shock wave treatment reduces neuronal degeneration
    The effect of shock waves on in vitro cartilage development in silk scaffolds

    The effect of shock waves on in vitro cartilage development in silk scaffolds

    The effect of shock waves on in vitro cartilage development in silk scaffolds 1.2 Dorota Szwarc¹,2, Christiane Fuchs12, Anna M. Weihs" Xavier Monforte Vila12, Dominik Hanetseder¹², Andreas H. Teuschl12, Dominik Rünzler¹.2 1 University of Applied Sciences Technikum Wien, Department of...
    Learn more about The effect of shock waves on in vitro cartilage development in silk scaffolds
    Shock wave therapy causes increased macrophage recruitment and enhances M2 polarization

    Shock wave therapy causes increased macrophage recruitment and enhances M2 polarization

      Objective: Shock wave therapy (SWT) has been shown to induce angiogenesis in ischemic muscle However, the mechanism of action remains unknown. Macrophages are crucial for angiogenic responses after ischemia. Proinflammatory M1 macrophages phagocytise necrotic tissue. M2 macrophages create a...
    Learn more about Shock wave therapy causes increased macrophage recruitment and enhances M2 polarization
    Extracorporeal Shock Wave Device for Treatment of Chronic Wounds

    Extracorporeal Shock Wave Device for Treatment of Chronic Wounds

    November 26, 2019Tissue Regeneration Technologies LLC℅ Jennifer DaudelinRegulatory Consultant IIIM Squared Associates, Inc575 Eight Avenue, St. Suite 1212New York, New York 10018 Re: K191961Trade/Device Name: OrthoGoldRegulation Number: 21 CFR 878.4685Regulation Name: Extracorporeal Shock Wave Device for Treatment of Chronic WoundsRegulatory...
    Learn more about Extracorporeal Shock Wave Device for Treatment of Chronic Wounds
    OrthoGold 100TM

    OrthoGold 100TM

    Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)   December 21, 2018 Tissue Regeneration Technologies, LLC o Jennifer Daudelin, MSJ Regulatory Consultant III M Squared Associates, Inc. 575 Eighth Avenue, Suite 1212 New...
    Learn more about OrthoGold 100TM
    FDA Devices and Indications

    FDA Devices and Indications

      Orthogold 100/ Dermagold 100* Orthogold 100/ Dermagold 100/ Urogold 100* FDA Device Class Class I, K182682 Therapeutic massager Class II, K191961 Extracorporeal Shock Wave Device for Treatment of Chronic Wounds Class II, K200926 Extracorporeal Shock Wave Device for Treatment...
    Learn more about FDA Devices and Indications
    CLEARANCES

    CLEARANCES

    Lithotriptor, Extracorporeal Shock-Wave, Urological – LithoGold Proprietary Name: LithoGold Classification Name: LITHOTRIPTOR, EXTRACORPOREAL SHOCK-WAVE, UROLOGICAL Product Code: LNS Device Class: 2 Regulation Number: 876.5990 Medical Specialty: Gastroenterology Registered Establishment Name: SOFTWAVE TISSUE REGENERATON TECHNOLOGIES, LLC Registered Establishment Number: 3006066512 Premarket...
    Learn more about CLEARANCES
    Find a provider Provider Portal